Cytori Therapeutics (CYTX) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CYTX Hot Sheet
Price: $0.21 --0%
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Cost of product revenues: 945K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Cytori Therapeutics (NASDAQ: CYTX) reported Q4 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.38 million versus the consensus estimate of $2.01 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
- Lucky Strike Entertainment Corporation (LUCK) reported Q2 Revenue ; Offers Guidance
- Hormel Foods (HRL) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
